Barbara Sennino

Company: Turnstone Biologics

Job title: Vice President, Immunotherapy

Seminars:

Enhancing TIL Selection to Enrich for the Optimal TIL Population 10:00 am

Developing selection methods to identify beneficial TIL populations Selection of TIL with a focused TCR repertoire to boost antitumor activity Expanding the most effective TIL to maximize tumor targeting abilityRead more

day: Day Two

Discussion Panel: Evaluating Use of Engineered TIL Vs Non-Engineered TIL to Outline Opportunities 3:45 pm

Comparing the benefits of both therapies from production, efficacy and ease of treatment in the clinic Highlighting the opportunity and niche where each therapy type will succeed to promote side by side development Discussing whether therapies will co-exist or outcompete to determine future focusRead more

day: Day One